NFG
RPRX icon

Next Financial Group’s Royalty Pharma RPRX Stock Holding History

Next Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$5K Sell
114
-12
-10% -$466 ﹤0.01% 2435
2021
Q3 		$4K Buy
126
+114
+950% +$4.43K ﹤0.01% 2333
2021
Q2 		$0 Hold
12
– – ﹤0.01% 2695
2021
Q1 		$1K Hold
12
– – ﹤0.01% 2454
2020
Q4 		$1K Hold
12
– – ﹤0.01% 2300
2020
Q3 		$1K Buy
+12
New +$515 ﹤0.01% 2135

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Next Financial Group's RPRX Position: Q4 2021 in Review

Next Financial Group reduced its Royalty Pharma (RPRX) stake by 9.5% in Q4 2021, selling an estimated $466 and leaving 114 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

Next Financial Group first reported a position in RPRX in Q3 2020 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold RPRX as of Q4 2021.

  • Next Financial Group held 114 shares of Royalty Pharma worth $5K as of Q4 2021.
  • Next Financial Group sold 12 Royalty Pharma shares in Q4 2021, an estimated $466.
  • Royalty Pharma made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2435 holding.
  • Next Financial Group first reported a position in Royalty Pharma in Q3 2020 and has held it in 6 quarters since.
  • 266 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.